Andrew Kolbert of Avomeen discusses FDA oversight of E&L testing, complications that arise, and the expertise needed to keep up with changing quality standards
The site now has a new Product Development & QC Lab area with 13 processing suites, two new packaging suites, serialization, and new manufacturing suites
Catalent will continue to manufacture BMS products while offering access to sterile biologics fill/finish and oral solids manufacturing and packaging platforms
Completes supply, installation, and validation spanning initial batch coding and serialization through aggregation, data management and third-party reporting